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still unsolved. To obtain a promising outcome in the long run, prompt osteointegration of the tendon 
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Abstract 
Anterior cruciate ligament reconstruction with a soft tissue autograft (hamstring 
autograft) has grown in popularity in the last 10 years. However, the issues of a 
relatively long healing time and an inferior histological healing result in term of 
Sharpey-like fibers connection in soft tissue grafts are still unsolved. To obtain a 
promising outcome in the long run, prompt osteointegration of the tendon graft within 
the bone tunnel is essential. In recent decades, numerous methods have been reported 
to enhance osteointegration of soft tissue graft in the bone tunnel. In this article, we 
review the current literature in this research area, mainly focusing on strategies 
applied to the local bone tunnel environment. Biologic strategies such as stem cell and 
gene transfer technology, as well as the local application of specific growth factors 
have been reported to yield exciting results. The use of biological bone substitute and 
physical stimulation also obtained promising results. Artificial engineered tissue has 
promise as a solution to the problem of donor site morbidity. Despite these 
encouraging results, the current available evidence is still experimental. Further 
clinical studies in terms of randomized control trial in the future should be conducted 
to extrapolate these basic science study findings into clinical practice. 
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Introduction 
Anterior cruciate ligament (ACL) reconstruction is one of the most common operations in the 
field of Sports Medicine.  It is estimated that there are more than 100,000 ACL reconstructions 
performed in the United States each year [18]. The graft used in the majority of ACL 
reconstructions is a biological graft [4]. The initial improved laxity is provided by the fixation 
strength of the implant, and the long term improved laxity depends on the healing of the graft 
within the host bone tunnel.  The success rate is typically expected to be greater than 90%.  
However, patients are required to abstain from pivoting motion sports activity for a period of three 
to nine months to minimize early failure. Such failure is usually secondary to a pulling out of the 
graft from the bone tunnel before osteointegration occurs [12].  
Soft tissue autograft (hamstring autograft) for ACL reconstruction has grown in popularity in 
the past 10 years [4, 32, 70].  The reported clinical results in terms of post-operative laxity, return 
to previous activity level and patient satisfaction are comparable with bone-patellar tendon-bone 
(BPTB) autograft, but the donor site morbidities are significantly less [3, 5-7, 13, 23, 29]. The 
commonly cited donor site problems of BPTB autograft include anterior knee pain, patellar 
tendonitis, difficulty in kneeling, extension loss, and potentially significant complications such as 
patellar tendon rupture and patella fracture [10, 33, 38]. The commonly reported disadvantages of 
hamstring autograft are knee flexion weakness, internal rotation weakness and decreased flexion 
range of the knee joint. These problems are due to the degraded function of the hamstrings and all 
of them are mild [1]. Thus, many surgeons prefer to use the hamstring autograft as the choice of 
graft in performing ACL reconstruction. 
Despite the high success rate of ACL reconstruction, it is noted that the number of revision 
ACL reconstruction procedures is approximately 3,000 to 10,000 in the United States annually 
[14].  Repeated trauma, incorrect tunnel positioning, implant failure and delayed healing of the 
graft within the bone tunnel are potential reasons for this outcome [12]. The anticipated graft 
incorporation within the bone tunnel is expected to be longer in ACL reconstruction performed 
with soft tissue biological grafts [16, 45].  Thus, many investigators are looking for methods for 
enhancing the biological healing of soft tissue graft within the bone tunnel to allow predictable 
osteointegration to occur within a certain minimal period of time. 
It is reported in previous studies that there are two types of healing patterns when a tendon is 
placed into a bone tunnel. One is a direct healing characterized by a fibrocartilage transition zone 
between the tendon and bone, resembling normal ACL insertion [20, 45, 62]. This healing pattern, 
however, can only be observed at the tunnel entrance [45, 47, 79] or at a later time point of the 
healing process [64].  Instead, in most cases, an indirect type of tendon healing is observable, and 
which is characterized by perforating collagen fibers that continue from the tendon into bone, and 
these fibers are named “Sharpey’s fibers” [16, 17, 26, 46, 47, 49, 55, 56, 71]. However, there is 
still no evidence that these Sharpey-like fibers are appropriate in returning function to normal. 
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Besides the inferior quality of the tendon-to-bone healing, another principal obstacle to tendon 
graft ACL reconstruction is the long healing time. The complete healing of the tendon graft takes 
several months [15, 56, 71], but the rehabilitation should start as soon as possible after the 
operation [63]. In the early healing period, the “weak site” is the tendon-bone interface [58]. 
Although instruments or suture techniques can provide temporary fixation, the risk for graft 
slippage and failure still raises concerns for surgeons. Hence, the patients are required to restrain 
from pivoting activities for a period of three to nine months to protect this interface before 
complete osteointegration into the tendon. Therefore, further investigation is needed to enhance 
the rate and quality of osteointegration of the tendon in bone tunnel. 
In recent decades, numerous methods have been reported to enhance tendon healing in the 
bone tunnel. In this article, we review the current literature in this research area, mainly focusing 
on the strategies applied to the local bone tunnel environment, and have made an attempt to 
identify the most appropriate and promising methods in this area. The related articles were 
obtained from the PubMed database using various combinations of the following key words: 
anterior cruciate ligament, reconstruction, tendon, graft, healing and osteointegration. Once an 
article was found, the “related articles” option of PubMed was used to further expand the search. 
We identified 31 articles which directly concerned the methodologies on enhancing tendon 
healing in bone tunnel in animal models (5 on bone substitutes; 6 on periosteum autograft; 13 on 
growth factors and gene therapy; 3 on stem cells; 2 on physical stimulation and 2 on artificial 
tissue engineering). As well, review of these articles yielded additional 52 relevant articles and 
hence totally 83 articles were included in our review paper. Even though this search was carried 
out with great rigor, it may not be complete. 
Natural tendon healing in bone tunnel 
The mechanisms of healing are complex and incompletely understood. At the beginning of the 
healing process, as early as 3~7 days after the tendon is placed into the bone tunnel, the gap 
between the tendon graft and bone tunnel is infiltrated with loose and poorly organized 
fibrovascular tissue. An inflammation reaction characterized by an influx of cells, such as 
fibroblasts, vascular endothelia, neutrophils and macrophages, is obvious within the tendon-bone 
interface with the expression of various growth factors and cytokines, such as type-III collagen, 
vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), bone morphogenetic 
proteins (BMPs) [20, 24, 28, 35, 56, 58]. Afterwards, at around 1~2 weeks, the interface tissue 
increases in cellularity and vascularity, with an increased number of osteoblasts, chondroid cells 
and fibroblasts around the bone tunnel wall. Bone growth factors, such as BMPs, are aggressively 
expressed and newly formed trabecular bone can be seen sparsely near the bone wall [20]. At 
approximately 4 weeks after the operation, the fibrovascular interface tissue become denser and 
better organized, and is gradually degraded by the chondroid cells from the bone into the tendon 
graft with a deposition of type-II collagen into the matrix, resulting in newly formed lamellar bone 
and early fibrocartilage progressively growing into the interface tissue. The bone wall surrounding 
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the tendon also has become thicker as a result of the new bone formation. However, during this 
stage, the collagen fibers are still poorly organized and the continuity between the tendon and 
bone can just occasionally be seen at this period. Later, at 6 weeks, the collagen fibers become 
more mature, and the continuity between the tendon and bone is reestablished. At around 8 weeks 
after the operation, perpendicular oriented fibers resembling Sharpey fibers can be seen along the 
axis of the tendon in the interface. These Sharpey-like fibers are composed of type-III collagen 
and connect the bone and the tendon graft, and are regarded as the earliest sign of osteointegration 
into the tendon [35, 56, 58]. As a result, the biomechanical outcomes of tendon healing at the early 
stage are essentially dependent on collagen fiber continuity and tendon osteointegration. ( Table 1) 
Tendon healing in this manner may be mostly attributable to the local biologic and 
biomechanical environment in the bone tunnel. The inflammatory reactions at the early stage lead 
to fibrosis rather than tissue regeneration [20, 26]. Moreover, insufficiency of undifferentiated 
cells in the tendon-bone interface makes tissue regeneration impossible [34]. Finally, the 
micromotion of the tendon continually taking place in the bone tunnel during the healing process 
results in chronic inflammation which impairs the osteointegration process [56-58, 60]. 
Bone substitutes  
Bone substitute materials have long been used in orthopaedics for bone defects and/or cavity 
filling. To fill the gap between the tendon and bone with bone substitute materials would seem to 
be clinically applicable. The bonding capability may lead to an instant improved laxity of the 
tendon graft in the bone tunnel [22, 54]. Moreover, with the capabilities of osteoinductivity and 
osteoconductivity, some materials can promote bone formation and therefore replace the defect 
with newly formed bone. To date, most studies have focused on calcium phosphate cements 
(CPC), with encouraging results. 
In 2004, Tien et al. [69] filled the tendon-bone interface with CPC in a rabbit ACL 
reconstruction model. As early as 3 weeks after the operation, they observed many growing bone 
islands within the CPC, and this new bone had formed directly on the surface of the bone and the 
tendon. By 6 weeks, the interface was almost completely filled by new bone with matured and 
well organized collagen fibers anchoring it. The interface appeared to have healed completely at 
24 weeks, as bone had integrated into the tendon. (Table 2 ) They did not see new bone formation 
in the control group until 12 weeks after the operation. Furthermore, better biomechanical 
properties were seen in the CPC augmented groups concerning early pullout strength in one week 
(6.51±1.33N compared with 2.05±0.95; P=0.03) and two weeks (11.49 ± 2.87N compared with 
5.45 ± 3.96N; P=0.03) post operation. 
Mutsuzaki et al. [41] reported a similar finding in a rabbit ACL reconstruction model. Before 
inserting the tendon into the bone tunnel, they soaked it in a Ca
2+
 solution and then a NaHPO4 
solution in turn so as to yield calcium phosphate crystal deposition on and between tendon 
collagen fibrils. They named the tendon treated in this manner the CaP-hybridized tendon. From 
the histological findings, they found the healing process was enhanced in the treated groups, with 
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 7 
newly formed bone seen almost all the way around the tendon as early as 2 weeks after surgery. 
According to their description, by CaP hybridization, the surface of the tendon became more 
bioactive. Both the osteoblasts and osteoclasts recognized this surface and their activity indicated 
it was a good place for interaction with each other. Therefore, new bone tissue formed on the 
tendon surface by the osteoblasts following CaP resorption by osteoclasts, and finally the tendon 
bonded to the bone tunnel directly. However, the authors did not test the mechanical effects.  
A more recent study, conducted by Huangfu and Zhao [22], used an injectable tricalcium 
phosphate(TCP) cement to fill the outer part of the bone tunnel after inserting the tendon graft in a 
dog ACL reconstruction model. From histologic examination, they discovered Sharpey-like fibers 
as early as 4 weeks after the operation on the experimental side, while only loose connective tissue 
on the control side. By 6 weeks after the operation, new bone and regular collagen fibers had filled 
the tendon-bone interface and the Sharpey-like fibers had became dense and more regular in the 
shape of bundles anchoring the new bone. However, on the control side, these Sharpey-like fibers 
could not be seen until 8 weeks after the operation. At 12 weeks, fibrocartilage and calcified bone 
were seen in the interface, demonstrating a direct ACL insertion appearance on the experimental 
side, while there were only dense fibers in the controls. (Table 2 ) Mechanical examination 
showed that the pullout strength was higher on the experimental side at 2 weeks(11.49±2.87N  
compared with 5.45±3.96N; P<0.05) and 4 weeks (62.90±7.62N, compared with 33.60±5.87N; 
P<.001) after the operation. 
In a biomechanical study, Tien et al. [69], in a rabbit ACL reconstruction model, found that at 
one week post operation, the CPC group had a mean maximal tensile strength of 6.51±1.33N, 
while the non-CPC group had 2.05±0.95N(P=0.03). In a study by Huangfu et al. [22], in a dog 
ACL reconstruction model, the ultimate pullout load at 2 weeks post-operation was found to be 
29.13±2.89N in the tricalcium phosphate group, compared to 14.43±4.20N on the control 
side(P<.001). Recently, Robertson et al. [54], in an in vitro study, used α-BSM calcium phosphate 
cement to fix the tendon graft within porcine femoral and tibial bone tunnels. All the specimens 
were underwent uniaxial tensile testing to failure after 4 hours storage in the incubator at 37°C. 
Their study showed that the mean load to failure for the tendon grafts in the femoral and tibial 
tunnels reached 71.7N and 90.62N respectively. Although all of the above mentioned studies 
showed significantly better tensile strength in treated group than in the non-treated group, the 
maximal pullout strength in these animal studies is extremely low. The superiority in the treated 
group may not be clinically significant if the results is extrapolated to human clinical studies.  
Another kind of injectbale bone substitute, magnesium-based bone adhesive, has been reported 
recently. Studies have shown that this kind of adhesive has better biomechanical properties 
comparing with calcium-based cement and can increase new bone formation in bone defects [78]. 
Gulotta et al. [19] injected this kind of material in the bone tunnel around the semitendinosus graft 
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in a rabbit ACL reconstruction model, and the histomorphometric analysis showed more 
fibrocartilage and less fibrous tissue in the treated interface at 6 weeks after the operation, with 
increased osteointegration also observed in the treated groups. The load-to-failure at 6 weeks after 
operation was up to 71.8±31.8N in the experimental limbs compared with 43.4±14.8N in the 
controls (P=.04). No significant inflammatory response or tissue necrosis observed in this study. 
However, the degradation characteristics of this magnesium-based bone adhesive were not well 
examined in this study. It is possible that nonabsorbable or slowly absorbed materials might 
interfere with the tendon-bone healing when applied to the tendon-bone interface. 
Bone substitute materials are easily available on the clinical market. Furthermore, they are 
not difficult to handle and can be quite convenient for filling the bone-tendon interface in the bone 
tunnel. However, there are some practical problems associated with the use of bone materials. 
These include the setting time, the potential dispersion on early contact with blood or aqueous 
media.  Besides, the injectable characteristics (e.g. viscosity, injectable time and cohesion) of the 
cement are essential in ACL reconstruction by arthroscopy techniques. 
Periosteum autograft  
Numerous experimental studies have demonstrated that the periosteum contains mesenchymal 
or multipotent stem cells which can induce bone and cartilage formation [21, 42, 52]. Some 
authors believe that filling the gap between the tendon and bone with periosteum autografts may 
provide undifferentiated cells to the tendon-bone interface and this results in better tendon healing 
results. 
In 2000, Ohtera, et al. [43] evaluated the effects of two types of periosteum on tendon-to-bone 
healing in the rabbit. In their study, a fresh periosteum was used in the left tibia and a frozen one 
was used in the right to wrap the long digital extensor tendon before insertion into the bone tunnel 
in the proximal tibial metaphysis. 4 weeks after the operation, the fresh specimen group produced 
a premature form of fibrocartilagenous attachment in the bone tunnel, while the frozen periosteal 
graft demonstrated simple fibrous tissue. Bone remodeling around the tendon graft could be seen 
in both groups, but was seen earlier in the fresh group. Chen et al. [8], also in a rabbit 
extra-articular model, sutured a proximal tibial periosteum on the surface of a long digitorum 
tendon and then placed it into a bone tunnel in the proximal tibia. They found a fibrovascular 
interface tissue formed by periosteal tissue between the tendon and bone in the early period of 4 
weeks post-operation. New bone was also seen interdigitated with this interface tissue. By 8 weeks, 
new bone was seen growing into this fibrous layer, it become integrated and mixed together with 
tendon and bone surface by 12 weeks after the operation. The failure load and the interface 
strength both progressively increased with time. However, no statistically significant difference 
was seen in failure strength between the experimental group and controls until 8 weeks post 
operation. 
Kyung et al. [30] reported a similar study in a rabbit model. They wrapped the long digital 
extensor tendon with periosteum before they transplanted it into a bone tunnel. From the 
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histological findings, they found collagen fibers in terms of granulation tissue in the experiment 
group at 3 weeks post-operation. These fibers perpendicularly connected tendon and bone, 
resembling Sharpey fibers. However, only poorly organized fibers were seen in the controls. At 6 
weeks after the operation, fibrous interface tissues were still seen in the control group, with less 
new bone formation and without any cartilaginous components. In contrast, the cartilaginous 
components increased in the periosteum treated group. Furthermore, the continuity of collagen 
fibers was increased and Sharpey-like fibers  obviously crossed the tissue junction 
perpendicularly. The biomechanical test showed that the treated group had better strength and 
failure load at ether 3 or 6 weeks post-operation. A more recent study, a rabbit model reported by 
Youn et al. [82], showed that periosteal augmentation of the tendon graft could enhance the 
structural integrity of the tendon-bone interface. (Table 3) In addition, when the fresh inner layer 
of periosteum was facing toward the bone tunnel, the significant new bone formation was highly 
organized around the bone tunnel and better mechanical strength was achieved in pullout test at 6 
weeks after operation (11.1±3.1 kg compared with 6.9±3.1kg; P<0.05).  
In clinical practice, autogeneous fresh periosteum is readily available and appears to be more 
applicable and promising than other biologic methods. Therefore, this technique may be feasible 
to apply to ACL reconstruction for the enhancement of tendon graft healing within the tunnel. 
Recently, the use of periosteum was further evidenced by a clinical study. In a prospective 
randomized study performed by Robert et al. [53], they found that the use of a periosteal flap can 
significantly reduce the tunnel enlargement at the outlet to the articular side. This study is a good 
start toward clinical application of the periosteum. However, whether application of periosteum to 
soft tissue grafts in ALC reconstruction will lead to a superior clinical outcome requires further 
randomized clinical trials preceded by a power analysis. 
Growth factors and gene therapy  
There is increasing interest in the use of biological agents to enhance tendon-bone 
osteointegration within the bony tunnel. A number of growth factors are known to have 
osteoinductive activity or activity that may modulate bone formation, such as bone morphogenetic 
proteins (BMPs), transforming growth factors (TGF) and fibroblast growth factors (FGF). It is 
possible that adding exogenous bone-growth factors to the local interface would result in a more 
favorable outcome. The most widely investigated bone-growth factors appear to be the BMPs. 
Both clinical and animal studies have shown that they can effectively induce new bone, cartilage, 
ligament, and tendon formation at both heterotopic and orthotopic sites [25, 40, 80]. 
Rodeo et al. [58] first used two different doses of recombinant human BMP-2(rhBMP-2) 
carried by an absorbable collagen sponge to fill the tendon-bone interface in the dog. As early as 7 
days after the operation, extensive new bone formation was seen in the high dose treated group, 
which effect, however, was accompanied by bone resorption. At 2 weeks, both doses of the BMP 
treated groups showed significant bone formation, but the low dose group also exhibited minor 
bone resorption. At 8 weeks in both of the treated groups, bone became closer to maturation and 
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the collagen fiber continuity was seen to have increased. In addition, the tendon treated with 
rh-BMP-2 exhibited greater adherence to bone at the early time point, 2 weeks after the operation, 
but not at four, six, or eight weeks. (Table 4) Later, Ma et al. [36], using a variety of doses 
rhBMP-2 in a rabbit ACL reconstruction model, found that new bone formation and integration to 
the tendon graft takes place in a dose-dependent manner when treated with rhBMP-2. Furthermore, 
the BMP treated groups exhibited a faster tendon healing process and greater stiffness at the 
tendon-bone junction than controls. These authors still found that bone resorption is not distinctly 
evident when using a slow delivering BMP carrier. Anderson et al. [2] reported a study on the 
effects of the product “Bone Protein”, which contains various bone-growth factors, on 
tendon-bone healing in a rabbit ACL reconstruction model. From the histologic results, there was 
extensive formation of new bone trabeculae and cartilage in the tendon-bone interface in the 
treated groups at 2 weeks after the operation, while only fibrovascular tissue had formed in 
controls. By 4 and 8 weeks after operation, the treated groups showed more consistent and denser 
tissue, with more cartilage and new bone formation in the interface. The new bone was in closer 
apposition to the tendon compared to the control groups. (Table 4) By application of bone growth 
factor into the healing interface, greater average ultimate load to failure was observed in the 
treated specimen at the individual 2 weeks (54.69N compared with 37.27N; P=0.04), 4 
weeks(65.82N compared with 39.44N; P=0.01), and 8-week(70.74N compared with 39.37N; 
P<0.001) after operation. 
Besides BMP-2, BMP-7 has also been investigated. In the study of Mihelic et al. [39], low 
dose BMP-7 (25μg) was applied to the bone-tendon interface in a sheep ACL reconstruction 
model. The histologic analysis showed that in the BMP treated group more extensive new bone 
had formed around the tendon, resulting in a distinct dense trabecular network connecting the bone 
and tendon. At three weeks post operation, the treated group had a mean pull-out force of 350 ± 
40N, while the control group had 212±28N (P<0.1). At six weeks after operation, the mean 
pull-out force reached 380±33N in the treated group and 215±44N in control group (P<0.1). More 
recently, Yamazaki et al. [81], in a beagle dog ACL reconstruction model, found that local 
administration of TGF-β1 enhanced not only perpendicular collagen fiber synthesis, but also new 
bone formation in the tunnel wall. Hence, the bonding strength of the tendon graft to the bony 
tunnel wall was observed to have been significantly increased at 3 weeks after the surgery. 
Another growth factor, Granulocyte colony-stimulating factor (G-CSF) was also shown to be able 
to enhance osteointegration of the tendon-bone interface by increased angiogenesis and 
osteogenesis [61]. In this study, Sharpey-like fibers were found as early as 4 weeks, compared to 
12 weeks in the natural healing process.  
As shown by the evidence provided above, the administration of growth factors at the time of 
surgery has been suggested to enhance the incorporation of a soft tissue graft into the bone tunnel. 
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However, to date, there are still certain limitations to the use of growth factors, one of which is the 
determination of the dose. Although some study demonstrated that healing outcomes might  be 
dose-dependent when a specific growth factor applied, the optimal dose for multiple factors is still 
unknown. Furthermore, the growth factor method is a one-time application to improve the healing 
results. The biological half-lives of these factors are typically in the range of minutes to hours. The 
long time effects on tendon healing are therefore questionable. Thus, choosing an acceptable 
delivery system to maintain the factors’ vitality while providing a stable delivery environment is 
required. One approach is to transfer the specific genes to the host cells, rather than to directly 
carry out local delivery of the growth factors themselves. Martinek et al. [37], in a rabbit 
reconstruction model, used gene transfer techniques to infect tendon grafts with the BMP-2 gene 
and evaluated the effects on bone integration into the tendon in the bone tunnel. At 2 weeks after 
the operation, a large number of osteoblasts with increased activity were observed filling in the 
interface in the treated specimens, and a broad, newly formed matrix showed a transition from 
fibrous to cartilageginous tissue to new bone along with the process of mineralization by the 
timepoint of 4 to 8 weeks after operation. On the other hand, only dense connective tissue formed 
in the control specimens. (Table 4) The biomechanical properties were significantly enhanced in 
the treated specimens in terms of stiffness (29.0 ± 7.1N/mm compared with 16.7±8.3 N/mm; 
p<0.05) and the ultimate load to failure (108.8±50.8N compared with 45.0±18.0N; p<0.05) 
compared with controls in eight weeks after operation. Two years later, a study by Lattermann et 
al. [31] further tested the feasibility of gene delivery to the ligament insertion site in the rabbit. 
They demonstrated sustained gene expression in the tendon-bone interface for up to 4 weeks.  
Gene transfer techniques appear to be favorable for altering cell behavior during the healing 
process, and provide a sustained delivery of growth factor throughout the early healing stage, 
which is a period of 4-6 weeks after operation. However, the appropriate length of availability of 
the growth factor in the local tendon-bone interface is still unknown. Moreover, for transferring 
genes to cells, specific recombinant viruses must be used. It is unknown how patients would 
tolerate such a virus. Furthermore, it is still unclear whether the cells of tendon or bone would be 
the better target. In the study of Lattermann et al. [31], they found that, the bone canal provides a 
more efficient target for direct adenoviral gene delivery than the tendon in the rabbit. Moreover, 
Kobayashi et al. [27] found that it is the host cells which contribute to the bone-tendon healing 
process rather than the graft cells. Taken together with the findings, it appears the cells from the 
bone tunnel would be a promising target for gene transfer. However, further studies are still 
required to make a strict comparison between these two targets. 
 
Stem Cell transplantation 
Stem cell technology rapidly developed over the recent decades. One of the most popular stem 
cell types, bone mesenchymal stem cells (MSC), have been extensively investigated and have 
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been shown to facilitate the formation of various structural and connective tissues, such as bone, 
cartilage, fat, tendon, and muscle [50, 51, 83]. Therefore, it may be reasonable to expect that bone 
MSCs would promote the regeneration of bone and fibrocartilage-like tissue under the specific 
environmental conditions of the tendon-bone interface. 
Ouyang et al. [44], in a rabbit model, used a fibrin glue to immobilize bone marrow stromal 
cells and then injected them into the bone tunnel after a hallucis longus tendon had been implanted. 
At 6 weeks post operation, greater perpendicular collagen fiber formation was seen in the 
experimental group  than the controls. In addition, cartilage-like cells proliferation, 
fibrocartilage-like tissue formation and collagen type II were seen only in the stem cell-treated 
specimens. In the control group, the soft tissue between the tendon and bone was mainly fibrous 
tissue parallel to the load axis, and direct collagen fibers similar to Sharpey’s fibers were observed 
to be only a slight amount after 6 week. Lim et al. [34] reported a similar finding in their study in 
the same year. They carried out bilateral ACL reconstruction in a rabbit model using hamstring 
autografts. The grafts were coated with fibrin glue before being inserted into the bone tunnel. 
Bone marrow mesenchymal stem cells (MSCs) were seeded in the fibrin glue in the experimental 
groups, while the fibrin glue remained blank in the controls. At 2 weeks after the operation, the 
interface in the control group consisted of only irregular vascular tissue and fibroblasts, whereas 
large crops of mature cartilage cells were seen filling in the interface in the experimental group. 
By 8 weeks, a mature and distinct fibrocartilage transitional zone from bone into the tendon grafts 
was seen in the MSC treated tendon. This zone stained strongly for type II collagen. In the 
controls, only mature scar tissue with some Sharpey’s-like fibers spanning the tendon-bone 
interface was observed. Biomechanical study revealed that MSC-enhanced grafts had significantly 
higher mean failure load (84.7N compared with 38.1N, P=0.02) and stiffness(32.6N/mm 
compared with 17.2N/mm, P=0.05) at 8 weeks post-operation. It was evident that MSC coating 
improves the healing process and results in better mechanical properties. More recently, the same 
research group [65] conducted a study to analyze the effects of BMSCs on enhancing 
osteointegration into an allograft tendon. They used similar techniques to create an ACL 
reconstruction rabbit model and coated the allograft tendon with autogeneous BMSCs in a fibrin 
glue carrier before insertion into the bone tunnel. They found that in the treated groups 
chondrocyte-like cells infiltrated around the interface by as early as 2 weeks after the operation, 
and these cells became more orderly at 4 weeks with a laying down of chondrosteoid matrix. By 8 
weeks, a transition zone demonstrating osteointegration could be seen in the treated groups which 
resulted in better biomechanical properties. In contrast, in the control group, the interface between 
tendon and bone was still distinct, with few collagen fibers but no collagen type II even as late as 
8 weeks after the operation. The histological results from this allograft study were very similar to 
that of the autograft study by the same research team [34]. (Table 5) 
Although exciting early results have been obtained, one of the mains limitations regarding stem 
cell technology is that it is inconvenient to clinical application because of the need for complicated 
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processes, such as bone marrow harvesting, stem cell culture, and cell differentiation and 
purification. The patient needs to wait about one month such processes before the reconstruction 
operation. Secondly, the stem cells used in the experiment are not labeled. As yet it has not been 
possible to determine the extent to which the stem cells play a role in fibrocartilage formation in 
the interface. Therefore, more studies are still required to demonstrate the specific role of the stem 
cells in the tendon-bone interface and also to develop a more convenient way to apply stem cells 
to the host. 
  
Inflammation modulatation techniques 
As discussed above, inflammation during the healing process may result in fibrosis rather 
than regenerated tissue. Hence, using biological techniques to moderate inflammation may 
improve the healing outcome. The macrophage is one of the most important inflammatory cells 
accumulating around the tendon graft from the earliest healing stage, and plays a critical role in 
the initiation and regulation of tendon healing [26]. Altering macrophage behavior might result in 
changes in the tendon-bone healing pattern. This was tested by the same group as described above 
more recently [20]. In a rat ACL reconstruction model, the experimental group was treated with 
clodronate to disable the macrophages. As a result, it was found that the healing outcome in the 
treated group was significantly improved in terms of enhanced new bone integration and better 
collagen continuity in the tendon-bone interface, but with less fibrosis tissue. The width of the 
interface was significantly reduced compared to the controls. Furthermore, better biomechanical 
properties were demonstrated in the treated group with respect to load to failure (13.5±4.2 N 
compared with 9.7±3.9 N; p < 0.05) and stiffness (11.5±5.0 N/mm compared with 7.5±3.2 N/mm; 
p < 0.05) in forty-two days after operation. It is known that macrophages produce matrix 
metalloproteinases(MMPs) which play a central role in extracellular matrix remodeling during the 
healing process. Demrirage et al. [11] used alpha-2-macroglobulin to block MMP activity in a 
rabbit ACL reconstruction model. In the treated specimens, there a greater number of areas of 
denser connective-tissue ingrowth with less cellularity and vascularity. The interface tissue was 
more mature and contained numerous perpendicular collagen bundles (Sharpey-like fibers). The 
ultimate load to failure was significantly greater in the treated specimens than in the controls at 
both two and five weeks after the operation. 
The biologic interactions between various cells within the tendon-bone interface during the 
healing process are complex. The role of the numerous cytokines involved in the healing process  
are still not well understood. It is also still unknown which is the best cell or cytokine target 
should be modified. The main purpose of biologic modulation is to avoid fibrosis scar healing and 
facilitate osteointegration. Further studies are required to improve our understanding of the 
tendon-bone-healing mechanism. 
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Artificial tissue engineering 
Using artificially engineered tissue to fill the gap between the tendon and bone is a novel 
approach to promoting tissue regeneration in the interface [48]. Recently, Chen et al. [9], used 
poly(ethylene glycol) diacrylate(PEGDA)-based polymers as the scaffold, periosteal progenitor 
cells(PPCs) as the seeded cells and BMP-2 as the growth factors. By photoencapsulation 
techniques, they created an injectabel hydrogel consisting of PEGDA, PPCs and BMP-2.  
Subsequently, the photopolymerized hydrogel was injected into the bone tunnel in the proximal 
tibial metaphysis after the tendon had been inserted in a rabbit model. Better histologic results 
were found in the treated groups in terms of a greater number of perpendicular fibers at the 
insertion,  the promotion of fibrocartilagenous attachment and new bone formation in the 
interface, along with significantly increased tendon pullout strength in either 3 weeks (37.3±7.3N 
compared with 27.1±3.8N; P<0.05)or 6 weeks (56.1±7.8N compared with 40.1±5.2N; P<0.05) 
after operation respectively. Spalazzi et al. [66] reported a study on an engineered multiphase 
scaffold for tendon integration into bone. In order to mimic the tendon-bone interface, they 
developed a novel triphased scaffold seeded with fibroblasts, chondrogytes and osteoblasts in the 
first, middle and last phase, respectively. Through an in vivo study in an athymic rat model, they 
found these three types of cells reacted well in the scaffold, with distinct mineral and 
fibrocartilage-like tissue formed. The host tissue infiltrated successfully into the engineered 
tissue. This tissue engineering product appears to help provide a functional interface between soft 
tissue and bone, and it may facilitate bone integration into the tendon when applied to the bone 
tendon gap in the bone tunnel in ACL reconstruction. 
 
Mechanical and physical stimulation 
Studies have shown that physical shock wave treatment can induce neovascularization and 
improve blood supply at the bone-tendon junction [74, 75].  It has also shown the ability to 
effectively stimulate new bone formation in acute or chronic non-union bone fracture [73, 77]. 
Therefore, this physical method has been used in an attempt to enhance the tendon-bone healing. 
Wang et al. [76] used a rabbit ACL reconstruction model to show a time-dependent effect of shock 
waves on the tendon-bone interface. New trabecular bone was seen to be significantly increased 
around the tendon graft at each time interval after 4 weeks of treatment. Furthermore, in the 
treated groups, the tendon grafts were largely surrounded by trabecular bone, while there was only 
fibrous tissue in the controls. The degree of contact between tendon and bone was significantly 
better in the treated groups. Another physical stimulation method is Low-intensity pulsed 
ultrasound (LIPUS).  This method has been shown to have positive effects on bone and ligament 
healing processes including angiogenic, chondrogenic and osteogenic activities [59, 67, 68]. 
Walsh et al. [72] used an intra-articular sheep model of ACL reconstruction to examine the LIPUS 
effects on tendon-bone healing. After the operation, LIPUS was applied daily for 20 minutes on 
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the lateral aspect of the femur in the treated groups. 3 weeks after the operation, new bone had 
formed at the margin of the bone tunnel in the experimental group, while there was only 
connective tissue in the controls. Sharpey-like fibers could be seen as early as 6 weeks in the 
treated group, but were not seen in the controls. The LIPUS treated specimens were significantly 
stiffer than controls in mechanical pull-out test at 3 weeks (P<0.02) and at 26 weeks (P<0.05) after 
operation. However, the difference of peak load between the treated ones and controls was only 
found statistically significant at 26 weeks (P<0.05). 
 
Conclusion  
There are many recent attempts which have been made to enhance the healing of soft tissue 
grafts within the host bone tunnel in ACL reconstruction. The stem cell technology utilized in 
recent rabbit models seems to be an approach to recreating the normal fibrocartilage tendon bone 
junction within a reasonably short period of time. However, the requirement of a separate 
operation for harvesting the stem cells and the time lag in multiplying the cell number may be 
obstacles to its use in clinical practice. Local application of specific growth factors on the graft 
during the time of ACL reconstruction is another attractive way to enhance osteointegration. 
However, the issues of the carrying vehicle, the optimal dosage and the effective duration of the  
release of the growth factor in human are still unsolved problems. The use of a biological bone 
substitute (e.g. tricalcium phosphate) is convenient, despite the fact that the time required for 
osteointegration is still suboptimal. Moreover, the injectable characteristics of the bone substitutes 
are not well examined in the animal studies at present moment. We do not know whether these 
materials are appropriate for ACL reconstruction by arthroscopy techniques. The development of 
an artificial biological graft (with the mechanical property of a native anterior cruciate ligament 
and prompt and anticipated osteointegration within the bone tunnel) using a tissue engineering 
technique on an artificial scaffold would be of great help in ACL reconstruction, as this would 
help eliminating the problem of donor site morbidity. However, the current research in this area at 
present is still limited to the promotion of graft-host bone interface healing. 
Despite these encouraging results, the current available evidence is still experimental. Although 
a number of studies provided statistically significant improved biomechanical results in the treated 
group, a practical question is that there is no data on the mechanical failure of the normal ACL in 
the animal model they studied. Thus, even though the tendon healing was enhanced in terms of 
improved biomechanical properties as treated with the specific intervention, we don't know if 
there is any clinical relevance. The current results in animal studies  still not evidence  more 
aggressive or earlier rehabilitation after ACL reconstruction. 
  In general, these recent efforts have remarkably improved the understanding of the healing of 
soft tissue graft with the host bone tunnel in the animal model of ACL. However, whether the 
results of these basic science studies can be extrapolated to clinical practice remains unanswered 
at the present moment. Future works in the form of well designed randomized controlled trial 
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should be conducted. 
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Table 1: Histological Characteristics Of Natural Tendon Healing Within Bone Tunnel At Different Time Intervals 
  ≤1 week 1~2 weeks 2~4 weeks 4~6 weeks 8~12 weeks 
Cells   Obvious inflammation 
reaction characterized by 
macrophages, neutrophils, 
fibroblasts and mononuclear 
cells dominant[20, 22, 26] 
Osteoblasts were seen [20, 
41] 
Osteoblasts increased and more 
active[37] 
 
 
Higher cellularity but 
less inflammation 
reaction[17, 22, 37, 56] 
Osteoblasts 
activated[37] 
 
 
Activated 
osteoblasts 
decreased [37] 
 
 
 
Adipose cells 
accumulation[69] 
 
 
 
Fibrous 
tissue 
 Fibrous tissue 1oose and 
irregular [20, 22] 
 
Fibrovascular tissue loose and poorly 
organized but highly cellularity and 
vascularity [20, 37, 56]  
 
 Denser, better 
organized and more 
mature fibrous tissue 
[20, 37, 41] 
Fibrous tissue 
become tense and 
remodeling[20, 22] 
Dense fibrous tissue 
connecting tendon to 
bone[37] 
 
Collagen 
fibers 
   Collagen fibers 
irregularly organized and 
continuity between 
tendon and to bone 
occasionally seen [20, 
41, 56, 69] 
Collagen fibers 
connecting tendon to 
bone[20] 
 
Sparse Sharpey-like 
fibers linking tendon 
and bone[17, 22, 56] 
 
 
 
Bone 
formation 
  Newly formed trabecular bone seen at 
10 days[20] 
 
Early fibrocartilage and 
more trabecular bone 
formed [20] 
 Osteoporotic change 
with thinner native 
trabecular bone [69] 
Table 1
  
 
 
 
 
 
 
 
 
 
 
 
Table 2  Histological Changes In Tendon-bone Interface With Bone Substitutes 
Method Authors 
 Time intervals 
≤1 week 2 weeks  3 weeks 4 weeks 6 weeks 8 weeks 10 weeks 12 weeks 24 weeks 
Bone 
substitutes 
CPC Tien 
2004[69] 
 CPC infiltrated the 
interface 
Thin layer of 
fibrous tissues 
 bone islands 
within CPC 
 
 
New bone 
infiltrated 
Collagen fibers 
matured and 
well organized  
  New bone 
infiltrated 
Collagen fibers 
continuity  
Bone ingrowth 
into the tendon 
Collagen fibers 
continuity 
between tendon 
and bone 
 CaP- 
hybridized 
Mutsuzaki 
 2004[41] 
 Red blood cells or 
fibrin clots in 3 
days 
Sparse fibrous 
tissue and new bone 
trabeculae at 5 days 
Osteoblasts and 
osteoclasts around 
the tendon 
Abundant esteoids, 
bone and 
cartilage-like tissue 
Osteoblasts and 
osteoclasts 
around the 
tendon 
New formed 
bone directly 
bound to tendon 
New formed bone 
increased and 
directly bound to 
tendon 
    
 TCP Huangfu 
2007 
[22] 
 TCP island 
surrounding with 
osteoblasts and 
fibrous tissue 
 Loose fibrous 
tissue 
New bone islands 
Sharpey-like 
fibers 
New formed 
bone 
Sharpey-like 
fibers 
 
New bone 
replaced TCP  
Sharpey-like 
fibers abundant 
and connecting 
tendon and bone 
Uncalcified 
fibrocartilage 
between 
tendon and 
new formed 
bone 
Normal ACL 
insertion 
appearance 
Sharpey-like 
fibers linking 
tendon and bone 
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Table 3  Histological Changes In Tendon-bone Interface With Periosteum Autografts 
Method Authors 
 Time intervals 
3 weeks 4 weeks 5 weeks 6 weeks 12 weeks 
Periosteum 
autografts 
Ohtera 
2000[43] 
  premature fibrocartilagenous 
in fresh grafts 
simple fibrous tissue in frozen 
grafts 
   
 Chen 
2003 [8] 
  Fibrovascular interface tissue  
New bone formation 
Bone mineralization and 
maturation  
Bone integration into tendon 
 Bone integration into tendon  
Collagen fiber remodeling 
Fibrocartilage formation 
 Kyung 
2003 [30] 
  Sharpey’s fibers connects the 
tendon to the bony wall 
Highly cellular, fibrovascular 
interface tissue 
Cartilaginous cells  
 Cartilaginous components  
Sharpey’s fibers crossing the 
tissue junction. 
Increased collagen fiber 
continuity 
 
 Youn, 
2004 [82] 
 New woven bone formatted  
Unorganized fibrous 
structure 
Chondrocytes at the 
cambium layer-bone 
interface. 
  
 
 
 
 
 
Significant new bone formation 
with a well-organized lamellar 
structure 
Tight interdigitation between 
the tendon graft at the cambium 
layer-bone interface 
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Table 4  Histological Changes In Tendon-bone Interface With Grow Factors and Gene Therapy 
 
Method 
 
Authors 
 Time intervals 
3 days 7 days 2 weeks 4 weeks 6 weeks 8 weeks 
Grow 
factors 
680μg 
rhBMP-2 
Rodeo 
1999[58]  
 Highly cellular 
granulation tissue 
Fibroblasts, 
Mesenchymal cells, 
Mononuclear cells  
Osteoclast-mediated 
resorption of the 
lamellar bone 
Extensive formation of 
new bone trabeculae 
More cellular fibrovascular 
interface tissue 
Bone resorption with 
extensive new bone 
formation 
New bone progressive 
mineralization 
Extracellular matrix and collagen 
fiber continuity Increased  
Cellularity and vascularity 
decreased 
  
 
New bone 
progressive 
mineralization 
Collagen fiber 
continuity 
increased 
 180μg 
rhBMP-2 
 
 
 
   Highly cellular 
fibrovascular interface 
tissue 
Minimal bone resorption 
with extensive new bone 
formation 
New bone progressive 
mineralization 
Extracellular matrix and collagen 
fiber continuity increased  
Cellularity and vascularity 
decreased  
 New bone 
progressive 
mineralization 
Collagen fiber 
continuity 
increased 
 Bone 
protein 
Anderson 
2001[2] 
   
 
 
 Extensive formation of 
new bone trabeculae and 
cartilage with closer 
apposition to tendon  
Cartilage and fibrovascular tissue 
more mature 
Better collagen-fiber continuity 
  More cartilage 
and new bone 
formation 
 BMP-2 
gene 
transfer 
Martinek 
2002[37]  
   Loose granulation-type 
tissue 
A large number of 
activated osteoblasts 
A broad layer of matrix formed 
resembling chondroosteoid 
depostion 
Transition zone 
from fibrous to 
cartilageginous 
tissue to new bone 
Transition zone 
like direct 
insertion more 
pronounced 
Table 4
  
 
 
 
Table 5  Histological Changes In Tendon-bone Interface With Inflammation Modulation and Stem Cells 
Method Authors 
 Time intervals 
≤1 week 2 weeks 4 weeks 5 weeks 6 weeks 8 weeks 
Inflammation 
modulation 
Macrophage 
apoptosis 
Hays 
2008[20] 
 Poorly organized collagen 
fibers  
Loose fibrovascular tissue 
Trabecu lar bone and Osteoid 
Distinct fibers continuity  
Dense fibrovascular tissue 
Fibrocartilage  
Osteoid increased 
Four-zone insertion site 
resemble direct healing  
Sharpey-like fibers 
increased 
 Osteoid formation   
 MMPs 
blocking 
Demirag 
2005[11] 
  Fibrous tissue with less 
cellularity and vascularity  
Sharpey-like fibers limited 
Collagen network 
longitudinally oriented 
 Denser connective 
tissue ingrowth 
Abundant 
perpendicular 
collagen fibers  
  
Stem cells BMSCs Ouyang 
2004[44]  
  Perpendicular collagen fibers 
Cartilage- like cells  
Fibrocartilage-like tissue 
 
Perpendicular collagen 
fibers 
Cartilage- like cells 
Fibrocartilage-like tissue 
Type I, II and III collagen 
 
 
 
 
Perpendicular collagen 
fibers 
Cartilage- like cells  
Fibrocartilage-like tissue 
Type I, II and III collagen 
 
 MSCs Lim 
2004[34]  
  Large crops of mature 
cartilage cells were seen 
filling in the interface 
Cartilage cells more 
organized 
Cartilage zone blended 
into the tendon substance 
 
 
 
 
 Cartilage cells matured 
Fibrocartilage 
transitional zone 
distinct 
 BMSCs 
allografts 
Soon 
2007[65] 
 Large area of immatured 
Chondrocyte-like cells  
 
Chondrocyte-like cells 
more matured and orderly 
Chondroosteoid matrix 
laying down, 
 
 
 
 
 Fibrocartilage 
transitional zone 
Abundant amount of 
collagen II 
 
 
 
 
Table 5
